Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)
- 6 January 2011
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 37 (4) , 619-626
Abstract
We performed a survey on acute heart failure (AHF) in nine countries in four continents. We aimed to describe characteristics and management of AHF among various countries, to compare patients with de novo AHF versus patients with a pre-existing episode of AHF, and to describe subpopulations hospitalized in intensive care unit (ICU) versus cardiac care unit (CCU) versus ward.Keywords
This publication has 10 references indexed in Scilit:
- Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart FailureJAMA, 2006
- Clinical Profile, Contemporary Management and One-Year Mortality in Patients with Severe Acute Heart Failure Syndromes: The EFICA StudyEuropean Journal of Heart Failure, 2006
- EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of populationEuropean Heart Journal, 2006
- Nationwide survey on acute heart failure in cardiology ward services in ItalyEuropean Heart Journal, 2005
- Acute Heart Failure: Clinical Presentation, One-Year Mortality and Prognostic FactorsEuropean Journal of Heart Failure, 2005
- Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)American Heart Journal, 2005
- Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of CardiologyEuropean Heart Journal, 2005
- The problem of decompensated heart failure: Nomenclature, classification, and risk stratificationAmerican Heart Journal, 2003
- Short-term Intravenous Milrinone for Acute Exacerbation of Chronic Heart FailureA Randomized Controlled TrialJAMA, 2002
- Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)American Heart Journal, 1999